1. Home
  2. TRST vs HROW Comparison

TRST vs HROW Comparison

Compare TRST & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TrustCo Bank Corp NY

TRST

TrustCo Bank Corp NY

N/A

Current Price

$57.67

Market Cap

858.9M

Sector

Finance

ML Signal

N/A

HROW

Harrow Inc.

N/A

Current Price

$28.30

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TRST
HROW
Founded
1902
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
858.9M
1.0B
IPO Year
1994
2008

Fundamental Metrics

Financial Performance
Metric
TRST
HROW
Price
$57.67
$28.30
Analyst Decision
Strong Buy
Analyst Count
0
9
Target Price
N/A
★ $62.63
AVG Volume (30 Days)
91.1K
★ 635.5K
Earning Date
10-21-2026
11-09-2026
Dividend Yield
★ 2.76%
N/A
EPS Growth
26.46
★ 71.43
EPS
★ 2.91
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$28.13
Revenue Next Year
N/A
$56.02
P/E Ratio
$19.90
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$38.60
$25.76
52 Week High
$59.96
$54.98

Technical Indicators

Market Signals
Indicator
TRST
HROW
Relative Strength Index (RSI) 57.38 47.12
Support Level $55.29 $27.75
Resistance Level $59.41 $30.28
Average True Range (ATR) 1.21 1.66
MACD 0.16 0.31
Stochastic Oscillator 46.85 35.42

Price Performance

Historical Comparison
TRST
HROW

About TRST TrustCo Bank Corp NY

Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The company derives revenue from the business of Banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey, and Vermont.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Share on Social Networks: